Biomarin Pharmaceutical - Registered Shares Overview

Biomarin Pharmaceutical - Registered Shares Gross Profit

Gross Profit analysis for BMRN.

Quarterly Gross Profit

$571.21M

↓ 3.77% YoY

As of Mar 31, 2026

Annual Gross Profit (TTM)

$2.46B

↓ 99.55% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin